Artificial Intelligence

The robotics firm is outsourcing key software development in a strategic move to reduce cash burn and speed its innovative surgical system to market.

Sweetgreen cashes out on its Infinite Kitchen tech, selling to Wonder for $186M. The deal signals a major shift in strategy and the food robotics industry.

The med-tech firm has submitted its AI-assisted capsule endoscopy module to the FDA, promising faster, more accurate, and accessible GI disease detection.

WISeKey's satellite arm, WISeSat, is merging with a SPAC to build a quantum-resilient IoT network, a key step in securing future global communications.

With soaring revenue and a landmark FDA approval for its Shield cancer test, Guardant Health's upcoming JPM presentation is poised to define its future.

The semiconductor equipment firm will release crucial 2025 and 2026 financial guidance in January, offering a key early test of the industry's momentum.

A private tender offer values diagnostics firm PathoCare at $1.75B. Can its AI-powered, non-invasive technology justify the price and transform medicine?

A new trading course blends a data expert's system with a NYSE veteran's insight. But can it tame the high-stakes world of zero-DTE options?

Autonomous AI is creating a massive talent shortage, reshaping tech careers and forcing companies to adapt or fall behind. Here’s what you need to know.

Millions miss their IELTS goals by a tiny margin. A new wave of AI tools promises instant feedback to help save dreams, deadlines, and thousands of dollars.

A new report details how interconnected apps, wearables, and AI are creating a 'Human Performance Economy' that extends far beyond the gym's walls.

A new deal links Mexico’s largest scouting academy with Spain's Cádiz CF, promising a direct route to European football for young talent.

After a swift restructuring, Modivcare emerges debt-light and privately owned, poised to aggressively invest in technology and transform supportive care.

Beyond tracking, a new AI mattress from Stareep promises to actively intervene and optimize your sleep. But is it a true revolution in a crowded market?

The location tech giant is bringing industrial-grade precision to the home, aiming to redefine smart living with spatially aware devices at CES 2026.

With promising survival data and a pivotal Phase 3 trial underway, Imunon's localized immunotherapy could finally change the game for ovarian cancer.

CES 2026 will see the debut of the xLean TR1, a robot vacuum that transforms into a handheld and claims to learn like a human. Is this the future?

Arizona State University just crossed $1 billion in research spending. This is the story of its disruptive rise and what it means for health, defense, and AI.

The premier investor summit returns with a global tour, new sessions on real estate, and a renewed focus on funding critical pediatric cancer research.

A new partnership aims to boost low colorectal cancer screening rates by combining trusted patient education with the promise of simpler blood-based tests.